Table 2.

Baseline anamnestic and clinical results after 6 weeks PTSD-therapy for patients without (control n = 22) and with splint therapy (n = 131)

	Control group		Splint therapy group
	Non-combat PTSD (A)	Combat-induced PTSD (B)	Non-combat PTSD (C)	Combat-induced PTSD (D)
Number	5	17	30	101
Age	26.0 ± 4.3	37.8 ± 10.0A	32.9 ± 10.4	36.9 ± 8.6C
IES revised	33.0 ± 0	52.2 ± 4.3A	37.3 ± 5.3	50.9 ± 7.3C
Time since last traumatic event (years)	0	5.3 ± 4.9A	1.0 ± 0	4.9 ± 3.3 C
mTWI	2.9 ± 0.6	3.6 ± 0.6 A	3.39 ± 0.8	3.75 ± 0.8C
Mouth opening (mm) BL vs 6 weeks	37.0 ± 9.1 vs 42.0 ± 7.6	42.2 ± 11.8 vs 43.8 ± 7.9	30.8 ± 7.8 vs 46.6 ± 4.5	30.8 ± 7.4 vs 48.5 ± 6.8
Pain (VAS 0-10) BL vs 6 weeks	6.8 ± 3.0 vs 4.0 ± 1.2	7.8 ± 0.8 vs 4.5 ± 1.3	7.4 ± 1.3 vs 2.7 ± 1.7	7.8 ± 1.1 vs 2.6 ± 1.2
Splints (n) during therapy	0	0	1.9 ± 1.0	2.1 ± 1.4

Results are based on two-sided tests assuming equal variances. For each significant pair, the key of the smaller category appears in the category with the larger mean. Capital letters indicate statistical significance at 0.05. Tests are adjusted for all pairwise comparisons within rows using the Bonferroni correction.